Roger Highfield OBE, Visiting Professor in Public Engagement
Trained as a chemist, with an undergraduate and DPhil from the University of Oxford, Roger has had a distinguished career as an author, science journalist and broadcaster. He has written 8 popular science books, and thousands of articles for platforms such as The Daily Telegraph (where he was Science Editor for 22 years) and the New Scientist, which he edited for more than three years. He is currently the Science Director of the Science Museum Group. Roger is also a Fellow of the Academy of Medical Sciences, a member of UKRI-Medical Research Council, and a visiting professor in the department of Chemistry at UCL.
Maria Leptin, Visiting Professor of Cell and Developmental Biology
Credit: EMBL Photolab
Maria studied mathematics and biology at the University of Bonn and the University of Heidelberg. She holds a PhD from the University of Heidelberg and conducted her PhD work at the Basel Institute for Immunology. After a postdoc at EMBL, she established her research group at the Max Plack Institute of Developmental Biology in Tübingen, and then became Professor at the University of Cologne, where she still leads a research group. She also runs a research group at EMBL, which focuses on the mechanics of shape determination during development. Maria was Director of EMBO from 2010-21 and is currently the President of the European Research Council (ERC). She is a Foreign Member of the Royal Society, an elected member of EMBO, The Academia Europaea and the German National Academy of Sciences, as well as an Honorary Fellow of the Academy of Medical Sciences.
Stephen Cusack, Emeritus Director of EMBL Grenoble Research Unit
Prof Cusack is a world leader in the structural biology of protein-RNA complexes in viral replication and innate immunity. He studied physics and theoretical physics at the University of Cambridge, followed by a PhD in theoretical solid-state physics at Imperial College. He changed focus to molecular biology during his postdoc at the EMBL Grenoble, where he later became a PI and eventually Head (1989-2022). His group is interested in the structures of protein-RNA systems in gene expression, viral replication and innate immunity, with some of his most notable projects concentrating on aminoacyl-tRNA synthetases, the RIG-I receptor and viral RNA-dependent RNA polymerases. He currently focuses on structural and mechanistic studies of the influenza virus polymerase. Prof Cusack co-founded Savira Pharmaceuticals for the development of anti-influenza drugs, and has collaborated with a number of pharmaceutical companies working on antiviral, antibacterial or anti-inflammatory compounds. He played a major role in the development of the X-ray crystallography facilities at the ESRF and was a co-founder of the Instruct-ERIC project, which aims to broaden access to structural biology technologies and techniques across Europe. He is a Fellow of the Royal Society and a member of EMBO, among other honours.